EyeGate Pharmaceuticals, Inc. EYEG
$ 1.95
-1.52%
EyeGate Pharmaceuticals, Inc. Financial Ratios 2011-2024 | EYEG
Annual Financial Ratios EyeGate Pharmaceuticals, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.6 | -2.6 | -1.6 | -1.2 | -1.2 | -1.2 | - | - | - | - |
P/S |
2394.5 | 6.8 | 10.5 | 38.5 | 23.6 | - | - | - | - | - |
EV/EBITDA |
-3.4 | -2.1 | -0.9 | -0.5 | -0.9 | -0.3 | - | - | - | - |
PEG |
0.25 | -0.05 | -0.02 | -0.03 | -0.03 | 0.0 | - | - | - | - |
P/B |
4.1 | 2.8 | 1.9 | -8.1 | -48.0 | 1.7 | - | - | - | - |
P/CF |
-3.9 | -2.2 | -1.6 | -2.4 | -1.9 | -2.3 | - | - | - | - |
ROE % |
-115.61 | -107.16 | -120.98 | 685.96 | 4050.57 | -137.89 | - | - | - | - |
ROA % |
-53.39 | -70.18 | -75.71 | -92.40 | -137.13 | -88.28 | - | - | - | - |
ROCE % |
-61.36 | -81.73 | -104.11 | 2756.68 | -550.94 | -109.71 | - | - | - | - |
DSO |
2753.6 | 0.7 | 4.1 | 21.2 | 29.4 | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - |
All numbers in USD currency